We adopt a patient-centric approach. Our star product, Diqing (Temozolomide Capsules) has opened new possibilities in the treatment of glioma. Our time-proven flutamide and Xihuang Wan have helped to reduce costs for patients with prostate cancer and breast cancer. We are developing drugs and devices meant for colon cancer, pancreatic cancer, liver cancer, and multiple myeloma, to aid in early detection, prevention, diagnosis, and treatment of tumors.